| Q45942528 | A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats |
| Q35591045 | Actions of neurotensin: a review of the electrophysiological studies |
| Q46595569 | Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist |
| Q48118949 | Alteration of neurotensin receptors in MPTP-treated mice |
| Q30401219 | An update on the connections of the ventral mesencephalic dopaminergic complex. |
| Q43840389 | Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain |
| Q36573433 | Coexistence of neuropeptides and "classical" neurotransmitters. Functional interactions between galanin and acetylcholine |
| Q48592456 | Colocalization of neurotensin in the mesocortical dopaminergic system. Restricted regional and laminar distribution in rat, lack of colocalization in human |
| Q48662501 | Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex |
| Q56903856 | Comparative distribution of neurotensin-like immunoreactivity in the brain of a teleost (Carassius auratus), an amphibian (Hyla meridionalis), and a reptile (Gallotia galloti) |
| Q35225133 | Cortical dopaminergic innervation among humans, chimpanzees, and macaque monkeys: a comparative study |
| Q35544527 | Current topics: brain penetrating neurotensin analog |
| Q71645753 | Demonstration of peptidergic afferents to the bed nucleus of the stria terminalis using local injections of colchicine. A combined immunohistochemical and retrograde tracing study |
| Q55265773 | Determination of neurotensin projections to the ventral tegmental area in mice. |
| Q48337654 | Developmental changes in neurotensin and its metabolites in the neonatal rat. |
| Q47948715 | Distribution of Neurotensin and Somatostatin-28 (1-12) in the Minipig Brainstem |
| Q48919404 | Distribution of neurotensin-containing fibers in the frontal cortex of the macaque monkey |
| Q33704191 | Does neurotensin mediate the effects of antipsychotic drugs? |
| Q64386018 | Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity |
| Q45346834 | Dopamine-neurotensin interactions in mesocortical neurons. Evidence from microdialysis studies |
| Q36649266 | Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates |
| Q48560682 | Double immunocytochemistry in pre-embedding electron microscopy for the detection of neurotensin and tyrosine hydroxylase in the guinea pig, using two primary antisera raised in the same species |
| Q74269233 | Effects of prefrontal cortex microinjection of neurotensin-(8-13) on midbrain dopamine and non-dopamine cell firing |
| Q43645441 | Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist. |
| Q73964518 | Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization |
| Q39298415 | Heterologous regulation of receptors on target cells of dopamine neurons in the prefrontal cortex, nucleus accumbens, and striatum |
| Q48091438 | Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat. |
| Q34245314 | Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence |
| Q42440896 | Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade |
| Q48962269 | Involvement of dopamine neurons in the regulation of beta-adrenergic receptor sensitivity in rat prefrontal cortex |
| Q39415008 | Mapping of neurotensin in the alpaca (Lama pacos) brainstem |
| Q52031561 | Medial prefrontal cortical output neurons to the ventral tegmental area (VTA) and their responses to burst-patterned stimulation of the VTA: neuroanatomical and in vivo electrophysiological analyses. |
| Q42130203 | Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex |
| Q48716522 | Mesocortical Neurotensin/Dopamine System: Is It Involved in the Pathogenesis of Schizophrenia? |
| Q35236820 | Mesocortical dopamine-neurotensin neurons. Possible opposite role of noradrenergic pathways on heteroregulations of dopamine (D1) and neurotensin postsynaptic receptors in the rat prefrontal cortex |
| Q36373006 | Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution. |
| Q36759399 | Multiplexed neurochemical signaling by neurons of the ventral tegmental area. |
| Q48256552 | Neurochemical development of the hippocampal region in the fetal rhesus monkey. I. Early appearance of peptides, calcium-binding proteins, DARPP-32, and monoamine innervation in the entorhinal cortex during the first half of gestation (E47 to E90). |
| Q28581544 | Neurotensin activates GABAergic interneurons in the prefrontal cortex |
| Q35152140 | Neurotensin agonists: possible drugs for treatment of psychostimulant abuse |
| Q48932372 | Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens |
| Q36449538 | Neurotensin and its receptors in the control of glucose homeostasis |
| Q50801783 | Neurotensin and neuromedin N elevate the cytosolic calcium concentration via transiently appearing neurotensin binding sites in cultured rat cortex cells |
| Q41774813 | Neurotensin binding to dopamine |
| Q44269721 | Neurotensin effect on Na+, K+-ATPase is CNS area- and membrane-dependent and involves high affinity NT1 receptor |
| Q89713011 | Neurotensin in reward processes |
| Q48769011 | Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity |
| Q33843327 | Neurotensin receptor 1 gene (NTSR1) polymorphism is associated with working memory |
| Q42478984 | Neurotensin regulation of endogenous acetylcholine release from rat cerebral cortex: effect of quinolinic acid lesions of the basal forebrain |
| Q58051244 | Neurotensin-induced excitation of neurons of the rat's frontal cortex studied intracellularly in vitro |
| Q48612312 | Neurotensin-lmmunoreactive Neurons in the Rat Medial Preoptic Area are Oestrogen-Receptive |
| Q34104228 | Pharmacology and behavioral pharmacology of the mesocortical dopamine system |
| Q48391814 | Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons |
| Q37862242 | Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment |
| Q37535927 | Stressor-induced anhedonia in the mesocorticolimbic system |
| Q35273482 | The current status of neurotensin-dopamine interactions. Issues and speculations |
| Q37800392 | The determinants of stress-induced activation of the prefrontal cortical dopamine system |
| Q27000238 | The multilingual nature of dopamine neurons |
| Q36466127 | The neurobiology of neurotensin: focus on neurotensin-dopamine interactions |
| Q44901393 | The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat. |
| Q38486467 | The striatal mosaic in primates: Patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum |
| Q92368420 | Transcriptional profiling aligned with in situ expression image analysis reveals mosaically expressed molecular markers for GABA neuron sub-groups in the ventral tegmental area |
| Q48656282 | Ultrastructural localization of neurotensin-like immunoreactivity within dense core vesicles in perikarya, but not terminals, colocalizing tyrosine hydroxylase in the rat ventral tegmental area |